Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
53 Cards in this Set
- Front
- Back
Alcohol Withdraw Tx
|
Benzodiazepines
|
|
Anorexia/Bulimia Tx
|
SSRIs
|
|
Anxiety Tx
|
Barbiturates, Benzodiazepines, Buspirone, MAO Inhibitors
|
|
Atypical Depression Tx
|
MAO Inhibitors
|
|
Bipolar Disorder Tx
|
Mood Stabilizers: lithium, Valproic acid, Carbamazepines
|
|
Depression Tx
|
SSRIs, TCAs
|
|
Depression with insomnia Tx
|
Trazodone, Mirtazapine
|
|
Obsessive/Compulsive Disorder Tx
|
SSRIs
|
|
Panic Disorder Tx
|
TCAs, Buspirone
|
|
Schizophrenia Tx
|
Antipsychotics
|
|
Thioridazine, Haloperidol, Fluphenazine, Chlorpromazine
|
Antipsychotics (Neuroleptics)
|
|
Antipsychotics (Neuroleptics) Mechanism
|
most blcok dopamine D2 receptors
|
|
Antipsychotics (Neuroleptics) Clinical Use
|
schizophrenia, psychosis, acute mania, Tourette syndrome
|
|
Antipsychotics (Neuroleptics) Toxicity
|
Extrapyramidal systme side effects, endocrine side effects, side effects arising from blocking muscarinic, α and histamine receptors, Neuroleptic Malignant Syndrome, Tardive Dyskinesia
|
|
Neuroleptic Malignant Syndrome and Tx
|
rigidity, myoglobinuria, autonomic instability, hyperpyrexia -- tx treat with dantrolene and dopamine agonists
|
|
Tardive Dyskinesia
|
stereotypic oral-facial movements probably due to dopamine receptor sensitization; results of long-term antipsychotic use
|
|
Clozapine, Olanzapine, Risperidone
|
Atypical Antipsychotics
|
|
Atypical Antipsychotics Mechanism
|
blocks 5-HT2 and dopamine receptors
|
|
Atypical Antipsychotics Clinical Use
|
schizophrenia (positive and negative), Olanzapine -- OCD, anxiety disorder, depression, mania, Tourette syndrome
|
|
Atypical Antipsychotics Toxicity
|
fewer EPS and anticholinergic side effects than other antipsychotics, Clozapine -- agranulocytosis
|
|
Lithium Mechanism
|
not established, possibly related to inhibition of phosphoinositol
|
|
Lithium Clinical Use
|
mood stabilizer for bipolar afffective disorder; blocks relapse and acute manic events
|
|
Lithium Toxicity
|
Tremor, hypothyroidism, polyuria (ADH antagonist causing nephrogenic diabetes insipidus), teratogenesis, Narrow therapeutic window, Requires monitoring
|
|
Buspirone Mechanism
|
Stimulated 5-HT1a receptors
|
|
Buspirone Clinical Use
|
Generalized Anxiety Disorder, does not cause sedation or addiction, does not interact with EtOH
|
|
Fluoxetine, Sertraline, Paroxetine, Citalopram
|
SSRIs, Normally takes 2-3 wks for antidepressants to have an effect
|
|
SSRIs Mechanism
|
Serotonin-specific reuptake inhibitors
|
|
SSRIs Clinical Use
|
Endogenous depression, OCD
|
|
SSRIs Toxicity
|
Fewer than TCAs. GI distress, sexual dysfunctions (anorgasmia)
|
|
Pt develops hyperthermia, muscle, rigidity and CV collapse after taking OTC cold medication - DX?
|
Serotonin Syndrom: May be induced with MAO -1's by tyramine ingestion (cheese, red wine, etc) or meperidine. SSRI and MAOI = Serotonin Syndrom
|
|
Imipramine, Amitriptyline, Desipramine, Nortriptyline, Clomipramine, Doxepin - Drug Class?
|
Tricyclic Antidepressants
|
|
TCA Mechanism
|
Blocks reuptake of NE and serotonin
|
|
TCA Clinical use
|
Major depression, bedwetting (imipramine), OCD (clomipramine)
|
|
TCA Side Effects
|
Sedation, α-blocking effects, atropine-like side effects (tachycardia and urinary retention)
|
|
TCA Toxicity
|
Convulsions, Coma, Cardiotoxicity, respiratory depression, hyperpyrexia. Confusion and hallucinations in elderly
|
|
Buproprian Clinical Use
|
depression, smoking cessation. (Mechanism not fully understood)
|
|
Buproprian Toxicity
|
tachycardia, insomnia, seizure in bulemic pats, does not cause sexual side effects
|
|
Venlafaxine Mechanism
|
inhibits serotinin, dopamine and NE reuptake
|
|
Venlafaxine Clinical Use
|
generalized Anxiety Disorder, Depression
|
|
Venlafaxine Toxicity
|
Stimulant effects, sedation, nausea, constipation, increased BP
|
|
Mirtazapine Mechanism
|
α2 antagonist --> increase release of NE and Serotonin, potent 5-HT2 and 5-HT3 receptor antagonist
|
|
Mirtazapine Clinical Use
|
depression
|
|
Mirtazapine Toxicity
|
sedation, increase appetite, weight gain, dry mouth
|
|
Maprotiline Mechanism
|
Blocks NE reuptake
|
|
Maprotiline Clinical Use
|
depression
|
|
Maprotiline Toxicity
|
sedation, orthostatic hypotension
|
|
Trazodone Mechanism
|
primarily inhibits serotonin reuptake
|
|
Trazodone Clinical Use
|
depression
|
|
Trazodone Toxicity
|
sedation, postural hypotension, nausea, priaprism
|
|
Phenelzine and Tranylcypromine
|
MAOIs
|
|
MAOI Mechanism
|
Nonselective MAO inhibition --> increase levels of amine neurotransmitters
|
|
MAOIs Clinical Use
|
Atypical depression (with psychotic or phobic features), also used in anxiety, hypochondriasis
|
|
MAOIs Toxicity
|
Hypertensive crisis with tyramine and meperidine, CNS stimulations. Contraindication with SSRIs or β-agonists
|